The drug rapamycin, which is in clinical trials for tuberous sclerosis (TSC), exacerbates features of fragile X syndrome, another condition related to autism, a new study suggests1.
Rapamycin increases anxiety, shortens sleep and worsens social skills in a mouse model of fragile X syndrome, the rese…